Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026)
Tarsus Pharmaceuticals' (TARS) quarterly Change in Inventory came in at $196000.0 in Q1 2026, up 133.33% year-on-year from $84000.0 in Q1 2025, and down 63.43% quarter-over-quarter from $536000.0 in Q4 2025.
Tarsus Pharmaceuticals (TARS) Change in Inventory (2023 - 2026) Analysis & Trends
Tarsus Pharmaceuticals' Change in Inventory history runs 4 years deep, the most recent figure standing at $196000.0 for Q1 2026.
- On a quarterly basis, Change in Inventory rose 133.33% year-over-year to $196000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 55.12% increase from a year earlier, with the FY2025 full-year figure at $1.8 million, down 14.42% from the prior year.
- Change in Inventory eased to $196000.0 in Q1 2026 per TARS's latest filing, from $536000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $3.1 million in Q4 2023 and bottomed at -$227000.0 in Q4 2024.
- The 4-year median for Change in Inventory is $536000.0 (2025), against an average of $645454.5.
- Biggest YoY gain for Change in Inventory was 4246.67% in 2024; the steepest drop was 107.34% in 2024.
- Year by year, Change in Inventory stood at $3.1 million in 2023, then slumped by 107.34% to -$227000.0 in 2024, then surged by 336.12% to $536000.0 in 2025, then tumbled by 63.43% to $196000.0 in 2026.
- Per Business Quant, the three latest TARS Change in Inventory figures stand at $196000.0 (Q1 2026), $536000.0 (Q4 2025), and -$37000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Tarsus Pharmaceuticals | 2.52 Bn | 2.41 Bn | 152.66 Mn | 196,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 196,000.00 |
| Mar 31, 2026 | 196,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Dec 31, 2025 | 536,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Sep 30, 2025 | -37,000.00 |
| Jun 30, 2025 | 1.17 Mn |
| Jun 30, 2025 | 1.17 Mn |
| Mar 31, 2025 | 84,000.00 |
| Mar 31, 2025 | 84,000.00 |
| Dec 31, 2024 | -227,000.00 |
| Dec 31, 2024 | -227,000.00 |
| Sep 30, 2024 | 652,000.00 |
| Sep 30, 2024 | 652,000.00 |
| Jun 30, 2024 | 692,000.00 |
| Jun 30, 2024 | 692,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Mar 31, 2024 | 929,000.00 |
| Dec 31, 2023 | 3.09 Mn |
| Dec 31, 2023 | 3.09 Mn |